Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
Apellis Pharmaceuticals(APLS) stock is priced at $17.98, giving the company a market capitalization of 2.3B. It carries a P/E multiple of 109.16.
During the trading session on 2026-03-18, Apellis Pharmaceuticals(APLS) shares reached a daily high of $18.59 and a low of $17.84. At a current price of $17.98, the stock is +0.8% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 529.8K, compared to an average daily volume of 1.91M.
The stock's 52-week range extends from a low of $16.10 to a high of $30.48.
The stock's 52-week range extends from a low of $16.10 to a high of $30.48.
APLS News
Apellis Pharmaceuticals recently added Mikael Dolsten, M.D., Ph.D., former chief scientific officer of Pfizer, to its board of directors, bringing decades of hi...
Analyst ratings
65%
of 23 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.